These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15077197)

  • 1. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.
    De Vos M; Hayward BE; Picton S; Sheridan E; Bonthron DT
    Am J Hum Genet; 2004 May; 74(5):954-64. PubMed ID: 15077197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in a pseudogene highly homologous to PMS2.
    Chadwick RB; Meek JE; Prior TW; Peltomaki P; de La Chapelle A
    Hum Mutat; 2000 Dec; 16(6):530. PubMed ID: 11102987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMS2 mutations in childhood cancer.
    De Vos M; Hayward BE; Charlton R; Taylor GR; Glaser AW; Picton S; Cole TR; Maher ER; McKeown CM; Mann JR; Yates JR; Baralle D; Rankin J; Bonthron DT; Sheridan E
    J Natl Cancer Inst; 2006 Mar; 98(5):358-61. PubMed ID: 16507833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
    Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
    Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
    de Vos M; Hayward B; Bonthron DT; Sheridan E
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
    Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
    Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
    Auclair J; Leroux D; Desseigne F; Lasset C; Saurin JC; Joly MO; Pinson S; Xu XL; Montmain G; Ruano E; Navarro C; Puisieux A; Wang Q
    Hum Mutat; 2007 Nov; 28(11):1084-90. PubMed ID: 17557300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
    De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
    Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
    Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
    Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range PCR facilitates the identification of PMS2-specific mutations.
    Clendenning M; Hampel H; LaJeunesse J; Lindblom A; Lockman J; Nilbert M; Senter L; Sotamaa K; de la Chapelle A
    Hum Mutat; 2006 May; 27(5):490-5. PubMed ID: 16619239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
    Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
    Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
    Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
    Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
    Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
    Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
    Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
    Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic PMS2 mutations and a distinctive childhood cancer syndrome.
    Tan TY; Orme LM; Lynch E; Croxford MA; Dow C; Dewan PA; Lipton L
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):254-7. PubMed ID: 18376293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.